First overseas facility planned for Bali in 2027 as Longevium develops cross-border care model for international patients
Dubai-based longevity medicine provider Longevium is preparing to take its healthcare model abroad, with its first international clinic scheduled to open in Bali in 2027. The planned facility is intended to serve both international patients travelling for medical programmes and residents seeking continuing preventive care.
The expansion is particularly significant for medical travel because Longevium plans to connect its facilities rather than operate them as independent clinics. Patients could begin a programme in Dubai, continue treatment abroad and subsequently return to the UAE for follow-up care, with medical information available to physicians across the network.
Bali clinic to cover 730 square metres
The new outpatient facility will cover approximately 730 square metres and is being developed in partnership with Nuanu founder Sergey Solonin.
Plans for the clinic include diagnostic assessments, digital health modelling, robotic blood collection, hyperbaric oxygen treatment and personalised recovery programmes. Regenerative therapies and other emerging treatments could be added depending on local regulatory approval.
The outpatient concept means patients will not require hospital admission or a residential stay, positioning the facility at the intersection of preventive healthcare, wellness and international medical travel.
Dubai network has served more than 30,000 patients
Longevium currently operates three clinics in Dubai and says its facilities have served more than 30,000 patients. Further expansion in the UAE is also planned, including a clinic in Abu Dhabi and a research laboratory at Dubai Science Park.
Founded by physician Dr Ksenia Butova, the group focuses on longevity and preventive medicine, combining medical consultations and diagnostic testing with digital technologies intended to support longer-term monitoring of individual patients.
“Most of what is sold as longevity is a menu of tests. Longevium stands for frontier medicine,” Butova said.
The international expansion now adds another dimension to that approach by attempting to make continuity of care possible when patients move between countries.
Digital records connect treatment locations
A digital platform developed by co-founder Sergey Shayakhmetov is intended to consolidate patients' medical histories and health data, allowing physicians to access relevant information when care continues at another location.
“Longevity medicine is only as good as its data,” Shayakhmetov said.
“Our platform holds a patient’s whole medical history, protects the data with the same rigour as the medicine itself, and tells the physician what matters now.”
For international healthcare providers, maintaining continuity when patients receive treatment in different countries is becoming increasingly important. Digital access to previous diagnostics, medical histories and treatment information could therefore become a central component of Longevium's international model.
From Dubai healthcare network to international patient pathway
The Bali project represents more than the geographical expansion of a Dubai clinic operator. Longevium is developing a model in which individual facilities form part of an international patient pathway.
That could allow Dubai to function both as a starting point and as a follow-up destination for patients receiving elements of their care elsewhere.
The Bali facility is scheduled to open in 2027, subject to regulatory requirements. If the model is successfully implemented, it would mark Longevium's transition from a UAE-based longevity clinic network to a cross-border healthcare operation built around preventive medicine, digital patient data and internationally mobile patients.
Image Credit: © AI generated illustration
